Article
Prognostic factors for overall survival in patients with chronic myeloid leukemia treated with imatinib at the National Cancer Institute – Mexico, from 2000 to 2016
Cancer Medicine
(2019)
Disciplines
Publication Date
May 2, 2019
DOI
10.1002/cam4.2201
Citation Information
Jimena Ylescas‐Soria, Alfredo H. de la Torre‐Lujan, Luis A. Herrera, Daniela Miranda, et al.. "Prognostic factors for overall survival in patients with chronic myeloid leukemia treated with imatinib at the National Cancer Institute – Mexico, from 2000 to 2016" Cancer Medicine (2019) Available at: http://works.bepress.com/fidias-leon-sarmiento/2/